The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A , D 2 and TAAR 1 receptors

De Gregorio, Danilo, Posa, Luca, Ochoa-Sanchez, Rafael, McLaughlin, Ryan, Maione, Sabatino, Comai, Stefano, Gobbi, Gabriella·2016·Pharmacological Research
DOI 10.1016/j.phrs.2016.08.022

Cited by (108)

Items 101–108 of 108

  1. Medical Use of Cannabinoids and Psychedelic Compounds
    Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi · 2024 · Springer eBooks
  2. Lysergic Acid Diethylamide (LSD) and the Heart: Exploring the Potential Impacts of LSD on Cardiovascular Function
    Akshita Suleria, Sakshi Verma, Khanij Arya, Mason T. Stoltzfus, Ira Gupta, Bhupinder Singh, Tanveer Ahamad Shaik · 2025 · Cureus
  3. Mécanismes d’action et perspectives thérapeutiques du LSD : état des lieux actuel
    Amel Bouloufa, Sarah Delcourte, Nasser Haddjeri · 2025 · Biologie Aujourd hui
  4. Additional file 1 of Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial
    Robin J. Murphy, Godfrey, Kate, Shaw, Alexander D., Muthukumaraswamy, Suresh, Rachael L. Sumner · 2024 · Figshare
  5. Lysergic acid diethylamide modulates hippocampal and cortical local field potential oscillatory rhythms in male mice
    Brenden Samuel Rabinovitch, N. Silverman, D. Ji, D Shizgal, Lewis EC, Peter Louis Carlen · 2026 · Brain Research
  6. Trip killers: Addressing a critical knowledge gap in psychedelic research
    Brian William O’Mahony, Colm Harrington, Andrew Harkin, Níall Lally · 2026 · Journal of Psychopharmacology
  7. Substanzgebrauchsstörungen
    Barbara Rohrmoser, Michael Koslowski · 2026 · Elsevier eBooks
  8. Schizophrenie
    Moritz Spangemacher, Gerhard Gründer · 2026 · Elsevier eBooks